[HTML][HTML] Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review
Background Patients with cancer‐associated venous thromboembolism (VTE) are
recommended to receive treatment with therapeutic anticoagulation for at least 3–6 months …
recommended to receive treatment with therapeutic anticoagulation for at least 3–6 months …
Epidemiology of cancer-associated thrombosis in Asia: a systematic review
The epidemiology of cancer associated thrombosis (CAT) in Asia is less well-studied and
differs from that in the western countries. Here, we systematically examine population based …
differs from that in the western countries. Here, we systematically examine population based …
[HTML][HTML] Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients
RX Deng, XL Zhu, AB Zhang, Y He, HX Fu… - … and Cellular Therapy, 2023 - Elsevier
As a serious complication after allogenic hematopoietic stem cell transplantation (allo-
HSCT), venous thromboembolism (VTE) is significantly related to increased nonrelapse …
HSCT), venous thromboembolism (VTE) is significantly related to increased nonrelapse …
[HTML][HTML] Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients
Background The fear of an early post-pancreatectomy haemorrhage (PPH) may prevent
surgeons from prescribing post-operative venous thromboembolism (VTE) …
surgeons from prescribing post-operative venous thromboembolism (VTE) …
Safe and effective treatment of venous Thromboembolism associated with Cancer: focus on direct Oral Anticoagulants in Asian patients
Cancer-associated thrombosis (CAT) poses a significant disease burden and the incidence
in Asian populations is increasing. Anticoagulation is the cornerstone of treatment, but can …
in Asian populations is increasing. Anticoagulation is the cornerstone of treatment, but can …
[HTML][HTML] Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
Results Of 124 patients enrolled, 110 (88.7%) had solid cancer, 93 (75.0%) had metastatic
disease, and 110 (88.7%) were receiving chemotherapy or radiotherapy. During the 6 …
disease, and 110 (88.7%) were receiving chemotherapy or radiotherapy. During the 6 …
Impact of pulmonary embolism on morbidity and mortality in patients undergoing pancreatic surgery
B Müssle, N Buck, S Schade, M Sommer… - … Archives of Surgery, 2021 - Springer
Purpose Postoperative pulmonary embolism (PE) after pancreatic surgery is a potentially life-
threatening complication. However, the magnitude of morbidity and mortality of PE is still …
threatening complication. However, the magnitude of morbidity and mortality of PE is still …
Young male's post appendectomy complication of pulmonary thromboembolism
The main goal of this report was to share with clinicians an atypical presentation of
PULMONARY THROMBOEMBOLISM (PTE) in a young male's POST-APPENDECTOMY …
PULMONARY THROMBOEMBOLISM (PTE) in a young male's POST-APPENDECTOMY …
术前血小板/淋巴细胞比值与胰十二指肠切除术后静脉血栓栓塞症的发生及预后的关系
吕志明， 文西年， 何铁英， 耿诚， 徐新建， 苏力担… - 肝胆胰外科 …, 2022 - gdy.qk.wmu.edu.cn
目的探讨术前血小板/淋巴细胞比值(PLR) 与胰十二指肠切除(PD) 术后静脉血栓栓塞症(VTE)
的发生及预后的关系. 方法回顾性分析2014 年1 月至2018 年12 月在新疆医科大学附属第一 …
的发生及预后的关系. 方法回顾性分析2014 年1 月至2018 年12 月在新疆医科大学附属第一 …